Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
Scientists Map How HIV Hijacks Human Cells—and How Cells Can Fight Back
Article
April 20, 2026
Scientists Map How HIV Hijacks Human Cells—and How Cells Can Fight Back
A new genetic roadmap reveals hundreds of hidden players in HIV infection, including two proteins that stop HIV in its tracks.
News Release Research (Publication) HIV/AIDS Genomic Immunology Krogan Lab Marson LabHow an Alzheimer’s Risk Gene Disrupts Brain Circuits Long Before Memory Loss
Article
April 3, 2026
How an Alzheimer’s Risk Gene Disrupts Brain Circuits Long Before Memory Loss
New findings on the APOE4 gene variant point to a potential therapeutic target for Alzheimer’s disease.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Aging Human GeneticsNew AI Model Predicts How Cells Age
Article
April 2, 2026
New AI Model Predicts How Cells Age
Trained on data spanning the human lifespan, a new tool developed at Gladstone can predict genes associated with aging and age-related diseases.
News Release Research (Publication) Cardiovascular Disease Theodoris Lab Aging